GEODE CAPITAL MANAGEMENT, LLC - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 22 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$214,000
-18.0%
858,4080.0%0.00%
Q4 2021$261,000
-40.3%
858,4080.0%0.00%
Q3 2021$437,000
-25.6%
858,408
+6.7%
0.00%
Q2 2021$587,000
-8.6%
804,290
+14.9%
0.00%
Q1 2021$642,000
+216.3%
700,038
+173.8%
0.00%
Q4 2020$203,000
-5.6%
255,6870.0%0.00%
Q3 2020$215,000
-35.0%
255,687
-24.8%
0.00%
Q2 2020$331,000
+501.8%
339,818
+95.1%
0.00%
Q1 2020$55,000
-76.1%
174,205
-65.3%
0.00%
Q4 2019$230,000
+1177.8%
502,326
+4893.3%
0.00%
Q3 2019$18,000
-35.7%
10,0600.0%0.00%
Q2 2019$28,000
-24.3%
10,0600.0%0.00%
Q1 2019$37,00010,0600.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Yu Fan 89,848$27,0000.31%
Virtu Financial LLC 151,310$46,0000.01%
Strategic Asset Management, LLC 2,000$1,0000.00%
Frontier Wealth Management LLC 25,000$8,0000.00%
St. Johns Investment Management Company, LLC 2$00.00%
UBS Group AG 52,652$16,0000.00%
OSAIC HOLDINGS, INC. 29,669$9,0000.00%
BANK OF AMERICA CORP /DE/ 190$00.00%
WELLS FARGO & COMPANY/MN 7,145$2,0000.00%
NORTHERN TRUST CORP 200,949$61,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders